India to expedite ethnics review for clinical drug trials

03/11/2013 | OutSourcing-Pharma.com

The Indian Central Drugs Standard Control Organisation announced that it is conducting an immediate technical review of applications from ethnics committees for proposed clinical trials, in response to declining clinical trial numbers reported last year and in response to criticism. The CDSCO will pay special attention to the issue of serious adverse events, which was a particular target of criticism by the U.S.-based Association of Clinical Research Organizations.

View Full Article in:

OutSourcing-Pharma.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park